Kee Pharma Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 10.48 Cr
as on 24-10-2024
- Company Age 33 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.50 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.50 Cr
as on 24-10-2024
- Revenue -2.77%
(FY 2023)
- Profit -2086.45%
(FY 2023)
- Ebitda -295.44%
(FY 2023)
- Net Worth -35.80%
(FY 2023)
- Total Assets -0.84%
(FY 2023)
About Kee Pharma
The Corporate was formerly known as Kee Pharma P Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.48 Cr.
The company currently has active open charges totaling ₹9.50 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kee Pharma Limited India are Anil Motihar as CFO and Manoj Mishra as Company Secretary. Anil Motihar, Harinder Motihar, and Varun Motihar serve as directors at the Company.
- CIN/LLPIN
U24239DL1991PLC044264
- Company No.
044264
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kee Pharma Limited offer?
Kee Pharma Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Respiratory System Drugs, Anti Asthma Drug, Herbal Cough Syrup, Ayurvedic Cough Syrup, Ayurvedic Herbal Syrups & Tonics, Diclofenac, Diclofenac Potassium Tablets.
Who are the key members and board of directors at Kee Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Motihar  | Managing Director | 09-Nov-1992 | Current |
| Manoj Mishra | Company Secretary | 15-Nov-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harinder Motihar | Director | 24-Jun-2006 | Current |
| Varun Motihar | Director | 11-Dec-2014 | Current |
Financial Performance of Kee Pharma.
Kee Pharma Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.77% decrease. The company also saw a substantial fall in profitability, with a 2086.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kee Pharma?
In 2023, Kee Pharma had a promoter holding of 84.65% and a public holding of 15.35%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 07 Oct 2004 | ₹2.95 Cr | Open |
Ge Capital Services India Creation Date: 11 Sep 2003 | ₹0.45 M | Open |
Nidian Bank Creation Date: 18 Oct 2002 | ₹7.50 M | Open |
How Many Employees Work at Kee Pharma?
Kee Pharma has a workforce of 222 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kee Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kee Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
